📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-13 12:54
122 analysed today
FollowTelegram
122
Today
149,523
All-time analysed
42,890
Positive
6,652
Negative
91,308
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
15 announcements match the current filters (relevance ≥ 5).
163% PAT Growth in Q1FY27; Revenue Surges to Rs 253 Cr on Inventory Gains
DMCC reported a sharp 99% YoY revenue growth to Rs 253.01 Cr for Q1FY27, with PAT jumping 163% to Rs 20.40 Cr. Management has explicitly cautioned that these results are 'optically strong' due to significant inventory gains from rising sulphur prices and are not structurally sustainable. The pricing environment has stretched working capital, leading to higher receivables, inventory balances, and a 72% YoY increase in interest costs from short-term borrowings. Despite global supply disruptions in the Strait of Hormuz, the company maintained full operational continuity at its Dahej and Roha plants.
Confidence: HIGH
What changedDMCC delivered a record quarterly performance in Q1FY27, nearly doubling its revenue YoY, primarily driven by a significant escalation in sulphur and sulfuric acid prices rather than structural volume expansion.
Why it mattersThe results highlight the company's ability to pass on cost increases and maintain supply during global disruptions, but the reliance on inventory gains suggests the current profitability level is temporary and has led to a stretched balance sheet.
Revenue (Q1FY27): Rs 253.01 CrPAT (Q1FY27): Rs 20.40 CrRevenue vs TTM Revenue: 43.5%EBITDA Margin: 13.59%YoY PAT Growth: 163.11%Interest Cost Increase (YoY): 72.30%
📅 Short termThe stock may see positive momentum from the headline growth, but the management's warning about non-sustainable inventory gains and stretched working capital may lead to volatility.
📈 Long termThe structural strength depends on the company's transition toward specialty chemicals and geographic diversification; the current quarter is an outlier due to commodity price spikes.
⚠ Risk flags
- Inventory gain reversal risk
- Stretched working capital
- Increased short-term debt
- Raw material price volatility (Sulphur)
Key Highlights
Revenue from operations grew 99.15% YoY to Rs 253.01 Cr, representing ~43.5% of TTM revenue in a single quarter.
Profit After Tax (PAT) increased by 163.11% YoY to Rs 20.40 Cr compared to Rs 7.75 Cr in Q1FY26.
EBITDA margins stood at 13.59%, an improvement of 355 bps over the immediate previous quarter (Q4FY26).
Interest costs rose 72.30% YoY to Rs 3.49 Cr, reflecting increased reliance on short-term debt to fund working capital.
Exports to Latin America, China, and Japan are successfully compensating for a subdued European market.
👀 What to Watch
Investors should monitor the trajectory of global sulphur prices, as management expects inventory gains to reverse and profits to normalize as prices moderate. Key metrics to watch in the next quarter include the reduction in working capital intensity and the stability of margins without one-off pricing benefits.
Rs 2.5 Divid e n d: DM C C S e t s A u g u s t 2 1, 2 0 2 6, a s R e c o r d D a t e
DM C C S p e c i a l i t y C h e m i c a l s h a s f i x e d A u g u s t 2 1, 2 0 2 6, a s t h e r e c o r d d a t e f o r i t s r e c o m m e n d e d f i n a l d i v i d e n d o f R s 2.5 p e r e q u i t y s h a r e (2 5% o f f a c e v a l u e). T h e d i v i d e n d i s s u b j e c t t o s h a r e h o l d e r a p p r o v a l a t t h e u p c o m i n g A G M o n S e p t e m b e r 1 1, 2 0 2 6. B a s e d o n t h e c u r r e n t p r i c e o f R s 2 8 8, t h i s r e p r e s e n t s a d i v i d e n d y i e l d o f a p p r o x i m a t e l y 0.8 7%. T h e c o m p a n y r e p o r t e d a T T M P A T o f R s 2 7 c r o r e f o r F Y 2 6.
Confidence: HIG H
What changedThe c o m p a n y h a s f o r m a l i z e d t h e t i m e l i n e f o r i t s p r e v i o u s l y r e c o m m e n d e d d i v i d e n d p a y m e n t f o r t h e f i n a n c i a l y e a r.
Why it mattersThis i s a r o u t i n e d i s t r i b u t i o n o f p r o f i t s t o s h a r e h o l d e r s, r e f l e c t i n g t h e c o m p a n y's a b i l i t y t o g e n e r a t e c a s h f l o w f r o m i t s R s 5 8 2 c r o r e T T M r e v e n u e b a s e.
Divid e n d p e r s h a r e: Rs 2.5Divid e n d y i e l d: 0.8 7%Recor d D a t e: 2 1-A u g-2 0 2 6AG M D a t e: 1 1-S e p-2 0 2 6Face V a l u e: Rs 1 0
📅 Short termThe s t o c k m a y e x p e r i e n c e a m i n o r p r i c e a d j u s t m e n t o n t h e e x-d i v i d e n d d a t e, t y p i c a l l y o n e b u s i n e s s d a y p r i o r t o t h e r e c o r d d a t e.
📈 Long termLimit e d; t h i s i s a p r o c e d u r a l a n n o u n c e m e n t r e l a t e d t o p a s t p e r f o r m a n c e r a t h e r t h a n f u t u r e g r o w t h c a p a b i l i t y.
⚠ Risk flags
- None m a t e r i a l
Key Highlights
Divid e n d r e c o m m e n d e d a t 2 5% o r R s 2.5 p e r e q u i t y s h a r e o f R s 1 0 f a c e v a l u e
Recor d d a t e f o r d e t e r m i n i n g e l i g i b i l i t y i s s e t f o r F r i d a y, A u g u s t 2 1, 2 0 2 6
Annual G e n e r a l M e e t i n g (A G M) t o b e h e l d o n S e p t e m b e r 1 1, 2 0 2 6
E-voting p e r i o d s c h e d u l e d f r o m S e p t e m b e r 8 t o S e p t e m b e r 1 0, 2 0 2 6
Payme n t w i l l b e m a d e w i t h i n 3 0 d a y s o f A G M a p p r o v a l
👀 What to Watch
Ensur e s h a r e s a r e h e l d i n t h e d e m a t a c c o u n t b y t h e r e c o r d d a t e (A u g 2 1) t o b e e l i g i b l e f o r t h e p a y o u t; p h y s i c a l s h a r e h o l d e r s m u s t u p d a t e K Y C d e t a i l s t o a v o i d w i t h h e l d p a y m e n t s.
163% YoY Profit Growth: DMCC Reports Strong Q1 FY27 Results with Rs 253 Cr Revenue
DMCC Speciality Chemicals reported a robust performance for Q1 FY27, with consolidated revenue surging 99% YoY to Rs 253.01 Cr from Rs 127.04 Cr. Net profit for the quarter jumped 163% YoY to Rs 20.40 Cr, compared to Rs 7.76 Cr in the year-ago period. The quarterly EPS of Rs 8.18 is a significant improvement over the Rs 3.11 reported in Q1 FY26 and represents a substantial portion of the total FY26 EPS (Rs 10.96). This growth indicates a successful scale-up of operations, although raw material costs have also risen to Rs 196.99 Cr.
Confidence: HIGH
What changedDMCC has significantly scaled its quarterly operations, moving from a historical revenue range of Rs 125-175 Cr to over Rs 250 Cr in Q1 FY27.
Why it mattersThe sharp increase in profitability suggests that the company's previously 'enhanced capacities' are now being utilized effectively, potentially leading to a structural shift in its earnings profile.
Consolidated Revenue (Q1 FY27): Rs 253.01 CrNet Profit (Q1 FY27): Rs 20.40 CrYoY Revenue Growth: 99.1%Q1 EPS: Rs 8.18Raw Material Cost % of Revenue: 77.8%
📅 Short termThe stock is likely to react positively in the short term due to the significant YoY and QoQ growth in both revenue and net profit.
📈 Long termIf DMCC sustains this quarterly performance, it could significantly outpace its FY26 annual revenue of Rs 581 Cr, marking a major growth phase for the company.
⚠ Risk flags
- High raw material cost sensitivity (78% of revenue)
- Limited pricing power in bulk chemical segments
- Volatility in global sulfur and benzene prices
Key Highlights
Consolidated revenue increased by 99.1% YoY to Rs 253.01 Cr.
Net profit surged by 162.9% YoY to Rs 20.40 Cr.
Quarterly EPS reached Rs 8.18, compared to Rs 3.11 in the same quarter last year.
Raw material consumption costs rose to Rs 196.99 Cr, accounting for 77.8% of total revenue.
Total expenses for the quarter stood at Rs 226.10 Cr, up from Rs 116.39 Cr YoY.
👀 What to Watch
Investors should monitor the sustainability of this higher revenue run-rate in upcoming quarters and track whether the company can maintain margins despite high raw material cost sensitivity.
DMCC Q4FY26 Revenue Jumps 42% YoY to ₹177.6 Cr; PAT Grows 18% Amid Supply Chain Hurdles
DMCC Speciality Chemicals reported a strong 41.87% YoY revenue growth in Q4FY26, reaching ₹177.64 crore, primarily driven by higher realizations in sulphuric acid following a spike in global sulphur prices. Despite geopolitical tensions in the Middle East causing raw material shortages at the Roha site, the company successfully passed on costs to maintain absolute profitability, with PAT rising 18.27% YoY to ₹7.65 crore. However, higher input costs have stretched working capital requirements, leading to increased short-term borrowings and a 53.75% YoY rise in interest costs. While the speciality chemicals segment shows early signs of recovery in overseas markets, management remains cautious due to ongoing global supply chain volatility.
Key Highlights
Revenue for Q4FY26 grew 41.87% YoY to ₹177.64 crore, while full-year FY26 revenue rose 34.84% to ₹581.58 crore.
Net Profit (PAT) for the quarter increased by 18.27% YoY to ₹7.65 crore, with FY26 PAT growing 26.95% to ₹27.33 crore.
EBITDA margins for Q4 stood at 10.05%, improving 179 bps sequentially but declining from 12.39% in the previous year's quarter.
Speciality chemicals contributed 31% of revenue, with management noting an encouraging uptick in inquiry flow from overseas markets.
Interest costs rose significantly by 53.75% YoY to ₹3.37 crore in Q4, reflecting the impact of short-term borrowings for working capital.
👀 What to Watch
Investors should monitor the company's ability to manage working capital and interest costs as supply chains stabilize. The recovery in the speciality chemicals segment and the company's success in passing on raw material hikes are positive indicators for medium-term growth.
DMCC Speciality Chemicals FY26 Net Profit Rises 27% to ₹27.3 Cr; Declares ₹2.50 Dividend
DMCC Speciality Chemicals reported a strong performance for FY26, with consolidated revenue growing 34.8% year-on-year to ₹581.6 crore. Net profit for the full year increased by 26.9% to ₹27.3 crore, supported by robust sales in the chemical manufacturing segment. The board has recommended a final dividend of ₹2.50 per share (25% of face value). However, investors should note a significant increase in short-term borrowings to ₹49.6 crore, which appears to be linked to a doubling of inventory levels to ₹91.9 crore.
Key Highlights
Consolidated FY26 revenue increased by 34.8% YoY to ₹581.58 crore.
Annual consolidated net profit grew by 26.9% to ₹27.33 crore from ₹21.53 crore in FY25.
Board recommended a final dividend of 25% (₹2.50 per equity share of ₹10 face value).
Inventory levels surged to ₹91.89 crore from ₹42.59 crore, contributing to higher short-term debt of ₹49.62 crore.
Full-year Consolidated Earnings Per Share (EPS) improved to ₹10.96 from ₹8.63.
👀 What to Watch
The company shows strong operational growth and maintains a healthy dividend payout; however, monitor the rising working capital and debt levels in future quarters. Long-term investors may find the growth trajectory in the speciality chemicals segment encouraging.
DMCC Speciality Chemicals Recommends Rs 2.50 Dividend; FY26 Net Profit Rises 27% YoY
DMCC Speciality Chemicals reported a strong financial performance for FY26, with consolidated revenue growing 34.8% to ₹581.58 crore. The company's annual net profit increased by 27% to ₹27.33 crore, reflecting improved operational efficiency despite a significant rise in raw material costs. In light of these results, the Board has recommended a final dividend of ₹2.50 per equity share (25% of face value). Quarterly performance was also robust, with Q4 revenue surging 42% year-on-year to ₹177.64 crore.
Key Highlights
Consolidated annual revenue increased to ₹581.58 crore in FY26 from ₹431.30 crore in FY25.
Net profit for the full year rose 26.9% to ₹27.33 crore compared to ₹21.53 crore in the previous year.
Recommended a final dividend of ₹2.50 per equity share of ₹10 each for FY26.
Annual Earnings Per Share (EPS) improved to ₹10.96 from ₹8.63 in the prior year.
Q4 FY26 consolidated net profit stood at ₹7.65 crore, a 18.3% increase over Q4 FY25.
👀 What to Watch
Investors should view the strong revenue growth and dividend recommendation positively as a sign of business scaling. However, keep a close watch on raw material consumption costs, which rose from ₹259 crore to ₹411 crore annually, potentially impacting future margins.
DMCC FY26 Net Profit Rises 27% to ₹27.3 Cr; Recommends ₹2.50 Dividend
DMCC Speciality Chemicals reported a strong performance for FY26, with consolidated total income growing by 34.7% to ₹582.6 crore compared to the previous year. Net profit for the full year increased by 26.9% to ₹27.3 crore, while Q4 profit saw an 18.5% year-on-year growth. The board has recommended a final dividend of 25% (₹2.50 per share). However, investors should note a significant increase in short-term borrowings and inventory levels as of March 31, 2026, which may impact future cash flows.
Key Highlights
FY26 Consolidated Total Income rose 34.7% YoY to ₹582.61 crore from ₹432.64 crore.
Annual Net Profit grew 26.9% to ₹27.33 crore with an EPS of ₹10.96 compared to ₹8.64 in FY25.
Board recommended a final dividend of ₹2.50 per equity share of ₹10 each.
Q4 FY26 revenue stood at ₹177.80 crore, up 41.5% compared to ₹125.66 crore in Q4 FY25.
Short-term borrowings surged to ₹49.62 crore from ₹7.56 crore in the previous year, alongside a doubling of inventory levels.
👀 What to Watch
The company shows robust top-line and bottom-line growth, making it a positive outlook for long-term investors. Monitor the rising debt and inventory levels in upcoming quarters to ensure working capital management remains efficient.
DMCC Shareholders Approve MD & CEO Re-appointment and MoA/AoA Changes with 99.99% Majority
DMCC Speciality Chemicals has successfully passed five key resolutions via postal ballot, all receiving over 99.99% shareholder support. A major outcome is the re-appointment of Bimal Lalitsingh Goculdas as MD and CEO for a three-year term effective April 1, 2026. Shareholders also approved the appointment of Saloni Jhaveri as an Independent Director and a salary revision for Executive Director Kuldeep Kumar Tiwari. Furthermore, the company received approval to modernize its Memorandum and Articles of Association, ensuring updated corporate governance frameworks.
Key Highlights
Bimal Lalitsingh Goculdas re-appointed as MD & CEO for a 3-year term from April 2026 to March 2029.
All five resolutions passed with an overwhelming majority of approximately 99.99% of votes cast.
Shareholders approved the appointment of Saloni Jhaveri as an Independent Director.
The company received authorization to alter its Memorandum and adopt new Articles of Association.
A total of 13,039,108 votes were polled, accounting for 52.28% of the total shareholding.
👀 What to Watch
The strong shareholder support for leadership continuity and governance updates is a positive indicator of stability. Investors should remain confident in the current management's strategic direction for the upcoming 2026-2029 period.
DMCC Seeks Shareholder Approval for MD Re-appointment and Board Changes
DMCC Speciality Chemicals has initiated a postal ballot to seek shareholder approval for the re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a three-year term effective April 1, 2026. The company is also proposing the appointment of Saloni Jhaveri as a Women Independent Director for a five-year term and a revision in the remuneration of Executive Director Kuldeep Kumar Tiwari. Additionally, resolutions include the alteration of the Memorandum of Association and adoption of new Articles of Association. The e-voting process concludes on March 15, 2026, with results expected by March 17, 2026.
Key Highlights
Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term (2026-2029)
Appointment of Saloni Jhaveri as Women Independent Director for a 5-year term starting January 2026
Revision of remuneration for Kuldeep Kumar Tiwari, Executive Director (Operations), effective April 1, 2026
Proposed updates to the Memorandum of Association (MoA) and Articles of Association (AoA)
E-voting period scheduled from February 13, 2026, to March 15, 2026
👀 What to Watch
Investors should support the resolutions to ensure leadership continuity, while keeping an eye on the specific details of the remuneration revision in the full explanatory statement.
DMCC Q3FY26 Revenue Up 28% YoY to ₹151 Cr; PAT Declines 22% on Margin Pressure
DMCC reported a strong 27.81% YoY growth in revenue to ₹150.87 crore for Q3FY26, driven by the resumption of the Boron business and improved realisations. However, EBITDA margins contracted significantly by 543 bps to 9.87% as elevated sulphur costs and a higher revenue base impacted percentages. While quarterly PAT fell 21.64% YoY to ₹6.17 crore, the 9-month performance remains robust with 9MFY26 PAT up 30.68% at ₹19.67 crore. The company expects the Boron segment to contribute ₹125-150 crore in annual revenue moving forward.
Key Highlights
Revenue from operations grew 27.81% YoY to ₹150.87 crore in Q3FY26.
EBITDA margins compressed by 543 bps YoY to 9.87% due to high raw material costs and pricing divergence.
Resumed Boron operations are projected to generate ₹125-150 crore in annual revenue.
9MFY26 PAT increased by 30.68% to ₹19.67 crore compared to ₹15.06 crore in 9MFY25.
Sustainability initiatives now contribute over 80% of the company's energy requirements through solar and waste heat recovery.
👀 What to Watch
Investors should monitor the stabilization of margins as the company navigates volatile sulphur prices and the full-scale ramp-up of the Boron business. The strong 9-month cumulative growth suggests underlying resilience despite the quarterly margin hit.
DMCC Re-appoints Bimal Goculdas as MD & CEO for 3 Years; Approves Q3 FY26 Results
DMCC Speciality Chemicals has approved the re-appointment of Bimal Lalitsingh Goculdas as Managing Director and CEO for a three-year term starting April 2026. The board also approved an increase in remuneration for Executive Director Kuldeep Kumar Tiwari and proposed significant updates to the company's Memorandum and Articles of Association to align with the Companies Act 2013. While the Q3 FY26 financial results were approved, the specific P&L figures were not detailed in the provided cover letter, though the auditor's review report was clean. These changes aim to provide better operational flexibility and governance alignment for the company.
Key Highlights
Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term from April 1, 2026, to March 31, 2029.
Proposed increase in remuneration for Shri Kuldeep Kumar Tiwari, Executive Director (Operations), subject to postal ballot approval.
Comprehensive update of Memorandum of Association (MOA) and Articles of Association (AOA) to align with the Companies Act 2013.
Approval of Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025.
The board meeting commenced at 1:00 p.m. and concluded at 3:05 p.m. on February 6, 2026.
👀 What to Watch
Investors should view the leadership continuity as a sign of stability for the company's long-term strategy. Monitor the upcoming Postal Ballot results and the detailed Q3 financial performance once fully released to assess operational growth.
DMCC Approves Q3 Results, Re-appoints CEO, and Proposes MOA/AOA Amendments
DMCC Speciality Chemicals has approved its unaudited financial results for Q3 FY26 and announced the re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a three-year term starting April 2026. The board also proposed significant amendments to the Memorandum and Articles of Association (MOA/AOA) to align with the Companies Act 2013 and provide greater operational flexibility for future activities. Additionally, a remuneration increase for the Executive Director of Operations was approved, subject to shareholder consent. These moves indicate a focus on leadership continuity and regulatory compliance.
Key Highlights
Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term from April 2026 to March 2029.
Proposed amendments to MOA Object and Liability clauses to align with Companies Act 2013 and enable future business flexibility.
Approval of remuneration increase for Kuldeep Kumar Tiwari, Executive Director (Operations), pending shareholder approval.
Consolidated results include subsidiary DMCC (Europe) GMBH, which contributed a nominal Rs 3.35 lacs to Q3 revenue.
Shareholder approval for management and regulatory changes to be sought via Postal Ballot.
👀 What to Watch
Investors should monitor the upcoming Postal Ballot notice for specific details on the expanded 'Object Clause' to identify potential new business segments. Leadership continuity is a positive sign for management stability.
DMCC Speciality Chemicals Approves Q3 FY26 Results and Re-appoints Bimal Goculdas as MD & CEO
DMCC Speciality Chemicals has approved its unaudited financial results for the quarter ended December 31, 2025, alongside key leadership decisions. The board confirmed the re-appointment of Bimal Lalitsingh Goculdas as MD and CEO for a three-year term effective April 2026, ensuring management continuity. Additionally, the company is seeking shareholder approval to amend its Memorandum of Association (MOA) to provide greater operational flexibility for future business activities. While the main entity's specific profit figures were not detailed in the text, its European subsidiary reported a marginal profit of ₹0.86 lacs for the quarter.
Key Highlights
Re-appointment of Bimal Lalitsingh Goculdas as MD & CEO for a 3-year term (2026-2029).
Proposed increase in remuneration for Kuldeep Kumar Tiwari, Executive Director (Operations).
Amendment of MOA 'Main Objects' clause to allow for future business expansion and flexibility.
Adoption of new Articles of Association (AOA) to align with the Companies Act, 2013.
Subsidiary DMCC (Europe) GMBH reported a net profit of ₹0.86 lacs for the quarter ended Dec 31, 2025.
👀 What to Watch
Investors should review the full financial statements once published to assess core profitability trends. The management continuity is a positive sign, but the proposed changes to the MOA objects clause should be monitored for signs of diversification into new business segments.
DMCC: Sonal Naik Resigns as Company Secretary & Compliance Officer
DMCC Speciality Chemicals Limited announced the resignation of Ms. Sonal Naik from the position of Company Secretary & Compliance Officer, effective December 16, 2025. Ms. Naik is leaving to explore opportunities outside the organization. Consequently, she will also cease to be a Key Managerial Personnel as per Section 203 of the Companies Act, 2013. The company is in the process of finding a suitable replacement.
Key Highlights
Ms. Sonal Naik resigned as Company Secretary & Compliance Officer.
Resignation effective from close of business hours on December 16, 2025.
Ms. Naik will cease to be Key Managerial Personnel on December 16, 2025.
ICSI Membership No. of Sonal Naik is ACS 43179.
👀 What to Watch
Investors should monitor the appointment of the new Company Secretary & Compliance Officer. This change is part of normal business operations.
DMCC: Supreme Court rules in favor regarding 52-acre land
DMCC Speciality Chemicals has announced that the Supreme Court of India ruled in its favor regarding a civil appeal. The appeal concerned a 52-acre piece of land in Nalimbi, near Ambernath, Taluka, Kalyan, which the government of Maharashtra had previously designated as Forest Land under The Maharashtra Private Forest (Acquisition) Act, 1975. The Supreme Court's decision quashes the previous orders and declarations, directing corrections in revenue records. DMCC will now take necessary steps as advised, potentially unlocking value from this land.
Key Highlights
Company owns 52 acres of land at village Nalimbi
Land was acquired under The Maharashtra Private Forest (Acquisition) Act, 1975
Civil appeal was filed before Supreme Court of India (SCI)
Supreme Court quashed orders treating land as 'Forest Land'
👀 What to Watch
Investors should monitor DMCC's actions regarding the 52-acre land and any potential impact on the company's financials. This ruling could positively affect the company's asset value.
